|
WO2021053564A1
|
|
Pharmaceutical composition comprising remogliflozin or salt or ester thereof and teneligliptin or salt thereof
|
|
WO2020229907A1
|
|
A medicament dispensing device
|
|
WO2020152548A1
|
|
Stable aerosol inhalation compositions of formoterol
|
|
WO2020089760A1
|
|
Fixed dose pharmaceutical composition comprising combination of remogliflozin or salt or ester thereof and vildagliptin or salt thereof
|
|
WO2020044223A1
|
|
Container system and pharmaceutical foam composition comprising betamethasone
|
|
WO2019234581A1
|
|
Pharmaceutical compositions of axitinib
|
|
WO2020165633A1
|
|
A pharmaceutical composition of gabapentin enacarbil or salt thereof
|
|
WO2019193572A1
|
|
An improved process for the preparation remogliflozin etabonate or pharmaceutically acceptable salt, solvate, hydrate thereof
|
|
WO2019162841A1
|
|
Pharmaceutical composition comprising remogliflozin for treatment of diabetes mellitus
|
|
BR112020017056A2
|
|
PHARMACEUTICAL COMPOSITION UNDERSTANDING REMOGLIFLOZINE AND AN ANTIDIABETIC AGENT
|
|
WO2019087172A1
|
|
Process for preparation of brivaracetam
|
|
US2020345671A1
|
|
Topical pharmaceutical composition of adapalene and minocycline
|
|
WO2019053607A1
|
|
Process for preparation of lifitegrast
|
|
WO2019048974A1
|
|
Process for the preparation of nintedanib
|
|
WO2018198102A1
|
|
Oral pharmaceutical formulations of remogliflozin
|
|
WO2018224923A1
|
|
Process for preparation of crisaborole
|
|
WO2018215908A1
|
|
Process for the preparation of deoxycholic acid
|
|
WO2018211410A1
|
|
Improved process for preparation of fosaprepitant or salt thereof
|
|
KR20180100554A
|
|
Formulations comprising oxalate salts of < RTI ID = 0.0 > Teneligliptin < / RTI > and solvates thereof
|
|
WO2018109622A1
|
|
Process for preparation of dydrogesterone
|
